Magnus Nylén

Direktör/Styrelseledamot på SELECTIMMUNE PHARMA AB (PUBL)

Health Technology

Consumer Services

Finance

Profil

Magnus Nylén is currently Director at Hamlet BioPharma AB starting in 2025.
Mr. Nylén is also Director at SelectImmune Pharma AB since 2022.
Additionally, Mr. Nylén has been Owner at Partner Fondkommission AB since 2013.
Mr. Nylén completed undergraduate education at Boston University.

Aktiva positioner av Magnus Nylén

Företag	Position	Start
SELECTIMMUNE PHARMA AB (PUBL)	Direktör/Styrelseledamot	2022-11-23
HAMLET PHARMA AB (PUBL)	Direktör/Styrelseledamot	2025-03-11
Partner Fondkommission AB Partner Fondkommission AB Investment ManagersFinance Offers financial advisory	Företagsledare/Principal	2013-01-01

Alla aktiva positioner av Magnus Nylén

Magnus Nyléns utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Magnus Nyléns erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Partner Fondkommission AB Partner Fondkommission AB Investment ManagersFinance Offers financial advisory	Finance
Hamlet BioPharma AB Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients	Health Technology
SelectImmune Pharma AB SelectImmune Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and manufactures immune enhancers to complement antibiotics	Health Technology